Showing results (281-290 of 5,669) with videos related to

Sort By:
Pageof 567
The Oncologist|October 17, 2019
Guillain-Barré Syndrome During Platinum-Based Chemotherapy: A Case Series and Review of the LiteratureEvangelia Pappa, Giulia Berzero, Bastien Herlin, et al.
The Oncologist|October 20, 2019
Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell LeukemiaRobert J Kreitman, Ira Pastan
The Oncologist|May 5, 2022
Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of LifeChristopher E Jensen, Sanah N Vohra, Kirsten A Nyrop, et al.
The Oncologist|April 28, 2022
Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical BenefitLori J Wirth, Cosimo Durante, Duncan J Topliss, et al.
The Oncologist|April 24, 2022
Blood-Based Next-Generation Sequencing in Adrenocortical CarcinomaBassel Nazha, Tony Z Zhuang, Hiba I Dada, et al.
The Oncologist|April 26, 2022
Real-World Study of Characteristics and Treatment Outcomes Among Patients with KRAS p.G12C-Mutated or Other KRAS Mutated Metastatic Colorectal CancerMarwan Fakih, Huakang Tu, Hil Hsu, et al.
The Oncologist|June 20, 2019
Empiric Therapy with BRAF and MEK Inhibitors in Metastatic MelanomaChristopher G Cann, Benjamin F Tillman, Elizabeth J Davis, et al.
The Oncologist|June 20, 2019
A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal TumorEvan Rosenbaum, Ciara Kelly, Sandra P D'Angelo, et al.
The Oncologist|July 4, 2019
Prognostic Impact of Pregnancy in Korean Patients with Breast CancerMihong Choi, Jiyeon Han, Bo Ram Yang, et al.
The Oncologist|October 13, 2019
The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRAUmut Disel, Russell Madison, Kumar Abhishek, et al.
Pageof 567